Datametrex Expands to Toronto Film Production Company for COVID-19 Testing Solutions

Toronto, Ontario–(Newsfile Corp. – September 30, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it received a Purchase Order (the “PO”) from a Toronto based film production company, Flatmate Productions Inc., a subsidiary of Cream Production Inc., to provide COVID-19 test kits and related screening solutions.

“With Toronto based production companies resuming to filming their projects, we feel that film production companies will be an important market for the Company to sell its COVID-19 tests and related services as Toronto is one of the largest film production locations in North America,” commented Marshall Gunter CEO of the Company.

In this respect, Ontario is one of the largest production centres in North America, representing approximately 34% of Canadian based film productions. Ontario’s film and television industry had a record-breaking year in 2019, with 343 productions bringing in approximately $2.16 billion in production spending for the economy. (Source: Government of Ontario: Record-breaking Year for Ontario’s Film and Television Industry)

Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits pursuant to the terms of the PO.

About Cream

Cream is a Toronto and LA based creative production company. They deliver distinctive and top-rated content to television and digital platforms around the world including Netflix, CNN, Hulu, PBS, Discovery Channel, History Channel, and the BBC. Additional information on Cream is available at www.creamproductions.com

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter: CEO
Phone: (514) 295-2300
Email: mgunter@datametrex.com

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Advertisement

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.